Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery
ConditionAnesthesia
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorBenha University
About this trial
Cesarean section (CS) is one of the most frequently performed surgical procedures globally, with an increasing demand for safe and effective anesthesia techniques. Regional anesthesia, particularly intrathecal anesthesia, has become the method of choice for elective cesarean deliveries.The most commonly used local anesthetic for intrathecal anesthesia is bupivacaine.Recent studies have focused on adjunctive agents to enhance the efficacy of local anesthetics.
Eligibility criteria
Qualifiers
(1) Full-term pregnant women undergoing elective cesarean section under spinal anesthesia. (2) Age: 20 ~ 35 years. (3) ASA physical status II ~ III
Disqualifiers
Multiple pregnancies.
Cardiovascular disease(e.g., pre-eclampsia and hypertension).
Serious hepatic dysfunction (Child-Pugh class C).
serious renal dysfunction (undergoing dialysis before surgery).
Trial design
Treatments tested in this trial
- Bupivacaine
- Bupivacaine and Dexmedetomidine
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov